Butyrate Supplementation in Liver Steatosis and Metabolic Syndrome: A Randomized Clinical Trial
Federica Fogacci, University of Bologna, Italy
Summary
Dr. Fogacci will present findings from a randomized clinical trial investigating the effects of butyrate supplementation on liver steatosis and metabolic syndrome. She will highlight butyrate’s potential to modulate gut microbiota, improve metabolic health, and reduce liver fat accumulation.
The results offer valuable data on its therapeutic role in managing metabolic disorders.
